Translating chitosan to clinical delivery of nucleic acid-based drugs

MRS Bulletin

Volumn 39, Issue 1, 2014, Pages 60-70

  Gomes, Carla Pereira ^a   Ferreira Lopes, Cátia Daniela ^a   Duarte Moreno, Pedro Miguel ^a   Varela Moreira, Aida ^a   Alonso, Maria José ^b   Pêgo, Ana Paula ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Universidade de Santiago de Compostela and Instituto de Investigación Sanitaria de Santiago de Compostela   (Spain)

Author keywords

biomaterial; biomedical; biomimetic; Chitosan; nanostructure; nucleic acid delivery

Indexed keywords

BIOMEDICAL; CATIONIC LIPOSOMES; CLINICAL PRACTICES; DELIVERY VEHICLE; NUCLEIC ACID DELIVERIES; POLYETHYLENE IMINES; SYNTHETIC MOLECULES; TRANSIENT TRANSFECTION;

BIOCOMPATIBILITY; BIOMATERIALS; BIOMIMETICS; BIOMOLECULES; CHITOSAN; MOLECULES; NANOSTRUCTURES;

NUCLEIC ACIDS; BIOMATERIALS;

EID: 84892752631     PISSN: 08837694     EISSN: None     Source Type: Journal    
DOI: 10.1557/mrs.2013.314     Document Type: Article

References (107)

1. P. Sorlier, A. Denuziere, C. Viton, A. Domard, Biomacromolecules 2, 765 (2001).
2. K. Kurita, Prog. Polym. Sci. 26, 1921 (2001).
3. M. Koping-Hoggard, K.M. Varum, M. Issa, S. Danielsen, B.E. Christensen, B.T. Stokke, P. Artursson, Gene Ther. 11, 1441 (2004).
4. M. Huang, C.W. Fong, E. Khor, L.Y. Lim, J. Controlled Release 106, 391 (2005).
5. M. Kannan, M. Nesakumari, K. Rajarathinam, A.J.A. R. Singh, Adv. Biol. Res. 4, 10 (2010).
6. B. He, L. Wang, J. Wang, G. Li, S. Zhang, Biologia 64, 819 (2009).
7. K.M. Varum, M.M. Myhr, R.J.N. Hjerde, O. Smidsrod, Carbohydr. Res. 299, 99 (1997).
8. K.M. Varum, H.K. Holme, M. Izume, B.T. Stokke, O. Smidsrod, Biochim. Biophys. Acta 1291, 5 (1996).
9. L. Liu, Y. Liu, H.D. Shin, R. Chen, J. Li, G. Du, J. Chen, Appl. Microbiol. Biotechnol. 97, 6149 (2013).
10. A.P. Pêgo, H. Oliveira, P.M. Moreno, in Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment (Springer, UK, 2013).
11. C. Uherek, W. Wels, Adv. Drug Delivery Rev. 44, 153 (2000).
12. S.A. Johnston, A.M. Talaat, M.J. McGuire, Arch. Med. Res. 33, 325 (2002).
13. K. Remaut, N.N. Sanders, F. Fayazpour, J. Demeester, S.C. De Smedt, J. Controlled Release 115, 335 (2006).
14. Food and Drug Administration, Guidance for Industry (Rockville, MD, 2007).
15. S. Mansouri, P. Lavigne, K. Corsi, M. Benderdour, E. Beaumont, J.C. Fernandes, Eur. J. Pharm. Biopharm. 57, 1 (2004).
16. K.Y. Lee, I.C. Kwon, Y.H. Kim, W.H. Jo, S.Y. Jeong, J. Controlled Release 51, 213 (1998).
17. N. Csaba, A. Sanchez, E. Fernandez-Megia, R. Novoa-Carballal, M.J. Alonso, Eur. J. Pharm. Sci. 23, S55 (2004).
18. Q. Gan, T. Wang, C. Cochrane, P. McCarron, Colloids Surf. B 44, 65 (2005).
19. S. Mao, W. Sun, T. Kissel, Adv. Drug Delivery Rev. 62, 12 (2010).
20. M.D. Buschmann, A. Merzouki, M. Lavertu, M. Thibault, M. Jean, V. Darras, Adv. Drug Delivery Rev. 65, 1234 (2013).
21. H.-Q. Mao, K. Roy, V.L. Troung-Le, K.A. Janes, K.Y. Lin, Y. Wang, J.T. August, K.W. Leong, J. Controlled Release 70, 399 (2001).
22. K. Wong, G. Sun, X. Zhang, H. Dai, Y. Liu, C. He, K.W. Leong, Bioconjugate Chem. 17, 152 (2006).
23. X. Jiang, H. Dai, K.W. Leong, S.H. Goh, H.Q. Mao, Y.Y. Yang, J. Gene Med. 8, 477 (2006).
24. N. Csaba, M. Koping-Hoggard, E. Fernandez-Megia, R. Novoa-Carballal, R. Riguera, M.J. Alonso, J. Biomed. Nanotechnol. 5, 162 (2009).
25. V.K. Mourya, N.N. Inamdar, J. Mater. Sci.-Mater. Med. 20, 1057 (2009).
26. T.H. Kim, J.E. Ihm, Y.J. Choi, J.W. Nah, C.S. Cho, J. Controlled Release 93, 389 (2003).
27. C. Moreira, H. Oliveira, L.R. Pires, S. Simões, M.A. Barbosa, A.P. Pêgo, Acta Biomater. 5, 2995 (2009).
28. F.Q. Hu, M.D. Zhao, H. Yuan, J. You, Y.Z. Du, S. Zeng, Int. J. Pharm. 315, 158 (2006).
29. H. Oliveira, L.R. Pires, R. Fernandez, M.C.L. Martins, S. Simões, A.P. Pêgo, J. Biomed. Mater. Res. Part A 95A, 801 (2010).
30. D. Lee, W. Zhang, S.A. Shirley, X. Kong, G.R. Hellermann, R.F. Lockey, S.S. Mohapatra, Pharm. Res. 24, 157 (2007).
31. B. Wang, C. He, C. Tang, C. Yin, Biomaterials 32, 4630 (2011).
32. N. Csaba, M. Koping-Hoggard, M.J. Alonso, Int. J. Pharm. 382, 205 (2009).
33. M. de la Fuente, B. Seijo, M.J. Alonso, Nanotechnology 19, 075105 (2008).
34. D. Teijeiro-Osorio, C. Remunan-Lopez, M.J. Alonso, Eur. J. Pharm. Biopharm. 71, 257 (2009).
35. F.C. Perez-Martinez, J. Guerra, I. Posadas, V. Cena, Pharm. Res. 28, 1843 (2011).
36. P. Chan, M. Kurisawa, J.E. Chung, Y.Y. Yang, Biomaterials 28, 540 (2007).
37. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, C.C. Mello, Nature 391, 806 (1998).
38. H. Katas, H.O. Alpar, J. Controlled Release 115, 216 (2006).
39. X. Liu, K.A. Howard, M. Dong, M.O. Andersen, U.L. Rahbek, M.G. Johnsen, O.C. Hansen, F. Besenbacher, J. Kjems, Biomaterials 28, 1280 (2007).
40. J. Malmo, H. Sorgard, K.M. Varum, S.P. Strand, J. Controlled Release 158, 261 (2012).
41. M. Alameh, D. Dejesus, M. Jean, V. Darras, M. Thibault, M. Lavertu, M.D. Buschmann, A. Merzouki, Int. J. Nanomed. 7, 1399 (2012).
42. P. Holzerny, B. Ajdini, W. Heusermann, K. Bruno, M. Schuleit, L. Meinel, M. Keller, J. Controlled Release 157, 297 (2012).
43. T. Rojanarata, P. Opanasopit, S. Techaarpornkul, T. Ngawhirunpat, U. Ruktanonchai, Pharm. Res. 25, 2807 (2008).
44. V. Dehousse, N. Garbacki, S. Jaspart, D. Castagne, G. Piel, A. Colige, B. Evrard, Int. J. Biol. Macromol. 46, 342 (2010).
45. A.K. Varkouhi, R.J. Verheul, R.M. Schiffelers, T. Lammers, G. Storm, W.E. Hennink, Bioconjugate Chem. 21, 2339 (2010).
46. S.M. Noh, S.E. Han, G. Shim, K.E. Lee, C.W. Kim, S.S. Han, Y. Choi, Y.K. Kim, W.K. Kim, Y.K. Oh, Biomaterials 32, 849 (2011).
47. H. Ragelle, G. Vandermeulen, V. Preat, J. Controlled Release 172, 207 (2013).
48. M. Ravina, E. Cubillo, D. Olmeda, R. Novoa-Carballal, E. Fernandez-Megia, R. Riguera, A. Sanchez, A. Cano, M.J. Alonso, Pharm. Res. 27, 2544 (2010).
49. P.C. Zamecnik, M.L. Stephenson, Proc. Natl. Acad. Sci. U.S.A. 75, 280 (1978).
50. E.M. Straarup, N. Fisker, M. Hedtjarn, M.W. Lindholm, C. Rosenbohm, V. Aarup, H.F. Hansen, H. Orum, J.B. Hansen, T. Koch, Nucleic Acids Res. 38, 7100 (2010).
51. S.T. Kim, C.K. Kim, Biomaterials 28, 3360 (2007).
52. S. Gao, J. Chen, L. Dong, Z. Ding, Y.H. Yang, J. Zhang, Eur. J. Pharm. Biopharm. 60, 327 (2005).
53. H.J. Hong, S.E. Jin, J.S. Park, W.S. Ahn, C.K. Kim, Biomaterials 29, 4831 (2008).
54. T. Gazori, M.R. Khoshayand, E. Azizi, P. Yazdizade, A. Nomani, I. Haririan, Carbohydr. Polym. 77, 599 (2009).
55. E. Azizi, A. Namazi, I. Haririan, S. Fouladdel, M.R. Khoshayand, P.Y. Shotorbani, A. Nomani, T. Gazori, Int. J. Nanomed. 5, 455 (2010).
56. T. Gazori, I. Haririan, S. Fouladdel, A. Namazi, A. Nomani, E. Azizi, Carbohydr. Polym. 80, 6 (2010).
57. T.H. Dung, S.R. Lee, S.D. Han, S.J. Kim, Y.M. Ju, M.S. Kim, H. Yoo, J. Nanosci. Nanotechnol. 7, 3695 (2007).
58. S. Ozbas-Turan, J. Akbuga, A.D. Sezer, Oligonucleotides 20, 147 (2010).
59. F. Talaei, E. Azizi, R. Dinarvand, F. Atyabi, Int. J. Nanomed. 6, 1963 (2011).
60. E. Kai, T. Ochiya, Pharm. Res. 21, 838 (2004).
61. H.L. Jiang, C.X. Xu, Y.K. Kim, R. Arote, D. Jere, H.T. Lim, M.H. Cho, C.S. Cho, Biomaterials 30, 5844 (2009).
62. M. de la Fuente, B. Seijo, M.J. Alonso, Invest. Ophthalmol. Vis. Sci. 49, 2016 (2008).
63. M. de la Fuente, B. Seijo, M.J. Alonso, Gene Ther. 15, 668 (2008).
64. K. Roy, H.Q. Mao, S.K. Huang, K.W. Leong, Nat. Med. 5, 387 (1999).
65. M. Bivas-Benita, M. Laloup, S. Versteyhe, J. Dewit, J. De Braekeleer, E. Jongert, G. Borchard, Int. J. Pharm. 266, 17 (2003).
66. M. Kumar, A.K. Behera, R.F. Lockey, J. Zhang, G. Bhullar, C.P. De La Cruz, L.C. Chen, K.W. Leong, S.K. Huang, S.S. Mohapatra, Hum. Gene Ther. 13, 1415 (2002).
67. M. Iqbal, W. Lin, I. Jabbal-Gill, S.S. Davis, M.W. Steward, L. Illum, Vaccine 21, 1478 (2003).
68. W. Zhang, H. Yang, X. Kong, S. Mohapatra, H. San Juan-Vergara, G. Hellermann, S. Behera, R. Singam, R.F. Lockey, S.S. Mohapatra, Nat. Med. 11, 56 (2005).
69. X. Kong, W. Zhang, R.F. Lockey, A. Auais, G. Piedimonte, S.S. Mohapatra, Genet. Vaccines Ther. 5, 4 (2007).
70. J.Y. Pille, H. Li, E. Blot, J.R. Bertrand, L.L. Pritchard, P. Opolon, A. Maksimenko, H. Lu, J.P. Vannier, J. Soria, C. Malvy, C. Soria, Hum. Gene Ther. 17, 1019 (2006).
71. http://clinicaltrials.gov (data from September 2013).
72. M.A. Barbosa, A.P. Pêgo, I.F. Amaral, in Comprehensive Biomaterials, P. Ducheyne, K. Healy, D.E. Hutmacher, D.W. Grainger, C.J. Kirkpatrick, Eds. (Elsevier, London, UK, 2011), pp. 221-237.
73. J. Shaji, V. Jain, S. Lodha, P.K.M. Kundnani, Int. J. Pharm. Appl. Sci. 1, 11 (2010).
74. W. Xu, Y. Shen, Z. Jiang, Y. Wang, Y. Chu, S. Xiong, Vaccine 22, 3603 (2004).
75. M. Bivas-Benita, K.E. van Meijgaarden, K.L. Franken, H.E. Junginger, G. Borchard, T.H. Ottenhoff, A. Geluk, Vaccine 22, 1609 (2004).
76. D. Raghuwanshi, V. Mishra, D. Das, K. Kaur, M.R. Suresh, Mol. Pharm. 9, 946 (2012).
77. C.R. Oliveira, C.M. Rezende, M.R. Silva, O.M. Borges, A.P. Pêgo, A.M. Goes, Sci. World J. 2012, 938457 (2012).
78. J.L. Chew, C.B. Wolfowicz, H.Q. Mao, K.W. Leong, K.Y. Chua, Vaccine 21, 2720 (2003).
79. M. Kumar, X. Kong, A.K. Behera, G.R. Hellermann, R.F. Lockey, S.S. Mohapatra, Genet. Vaccines Ther. 1, 3 (2003).
80. G.P. Li, Z.G. Liu, B. Liao, N.S. Zhong, Cell Mol. Immunol. 6, 45 (2009).
81. C.R. Dass, K.G. Contreras, D.E. Dunstan, P.F. Choong, Biomaterials 28, 3026 (2007).
82. M. Cheng, Q. Li, T. Wan, X. Hong, H. Chen, B. He, Z. Cheng, H. Xu, T. Ye, B. Zha, J. Wu, R. Zhou, J. Biomed. Mater. Res. Part B 99, 70 (2011).
83. Q.Q. Zhao, Y.L. Hu, Y. Zhou, N. Li, M. Han, G.P. Tang, F. Qiu, Y. Tabata, J.Q. Gao, Int. J. Nanomed. 7, 3191 (2012).
84. S. Feng, I.U. Agoulnik, A. Truong, Z. Li, C.J. Creighton, E.M. Kaftanovskaya, R. Pereira, H.D. Han, G. Lopez-Berestein, T. Klonisch, M.M. Ittmann, A.K. Sood, A.I. Agoulnik, Endocrinol. Relat. Cancer 17, 1021 (2010).
85. H.S. Kim, H.D. Han, G.N. Armaiz-Pena, R.L. Stone, E.J. Nam, J.W. Lee, M.M. Shahzad, A.M. Nick, S.J. Lee, J.W. Roh, M. Nishimura, L.S. Mangala, J. Bottsford-Miller, G.E. Gallick, G. Lopez-Berestein, A.K. Sood, Clin. Cancer Res. 17, 1713 (2011).
86. H.D. Han, E.M. Mora, J.W. Roh, M. Nishimura, S.J. Lee, R.L. Stone, M. Bar-Eli, G. Lopez-Berestein, A.K. Sood, Cancer Biol. Ther. 11, 839 (2011).
87. Z. Huang, L. Dong, J. Chen, F. Gao, Z. Zhang, J. Chen, J. Zhang, Life Sci. 91, 1207 (2012).
88. S.J. Lee, M.S. Huh, S.Y. Lee, S. Min, S. Lee, H. Koo, J.U. Chu, K.E. Lee, H. Jeon, Y. Choi, K. Choi, Y. Byun, S.Y. Jeong, K. Park, K. Kim, I.C. Kwon, Angew. Chem. Int. Ed. 51, 7203 (2012).
89. K. Bowman, R. Sarkar, S. Raut, K.W. Leong, J. Controlled Release 132, 252 (2008).
90. K.A. Howard, S.R. Paludan, M.A. Behlke, F. Besenbacher, B. Deleuran, J. Kjems, Mol. Ther. 17, 162 (2009).
91. M. Jean, M. Alameh, M.D. Buschmann, A. Merzouki, Gene Ther. 18, 807 (2011).
92. Council of Europe, European Pharmacopeia (Strasbourg, 2002).
93. United States Pharmacopeia and the National Formulary, United States Pharmacopeial Convention (Baltimore, United Book Press, 2011), vol. 29, p. 5361.
94. US Food and Drug Administration Gras Notice Inventory (consulted online 2013: http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ default.htm).
95. J.S. Boateng, K.H. Matthews, H.N. Stevens, G.M. Eccleston, J. Pharm. Sci. 97, 2892 (2008).
96. M.H. Struszczyk, " Global Requirements for Medical Applications of Chitin and its Derivatives," in Monograph XI (Polish Chitin Society, Poland, 2006).
97. ASTM Standard F2103, "Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications" (ASTM International, West Conshohocken, PA, 2011).
98. A.J. Varma, S.V. Deshpande, J.F. Kennedy, Carbohydr. Polym. 55, 77 (2004).
99. V. Bansal, P.K. Sharma, N. Sharma, O.P. Pal, R. Malviya, Adv. Biol. Res. 5, 28 (2011).
100. M.D. Buschmann, A. Merzouki, M. Lavertu, M. Thibault, M. Jean, V. Darras, Adv. Drug Delivery Rev. (2013), accepted for publication.
101. O. Skaugrud, A. Hagen, B. Borgersen, M. Dornish, Biotechnol. Genet. Eng. Rev. 16, 23 (1999).
102. ASTM Standard F2260, 2012e1, "Standard Test Method for Determining Degree of Deacetylation in Chitosan Salts by Proton Nuclear Magnetic Resonance (1H NMR) Spectroscopy" (ASTM International, West Conshohocken, PA, 2012).
103. K.M. Varum, M.W. Anthonsen, H. Grasdalen, O. Smidsrod, Carbohydr. Res. 211, 17 (1991).
104. ASTM Standard F2602, 2008e1, "Standard Test Method for Determining the Molar Mass of Chitosan and Chitosan Salts by Size Exclusion Chromatography with Multi angle Light Scattering Detection (SEC MALS)" (ASTM International, West Conshohocken, PA, 2008).
105. US Food and Drug Administration, "Guidance for Industry-Pyrogen and Endotoxins Testing" (2012); www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM310098.pdf.
106. L.R. Pires, H. Oliveira, C.C. Barrias, P. Sampaio, A.J. Pereira, H. Maiato, S. Simoes, A.P. Pêgo, Nanomedicine 6, 1499 (2011).
107. F. Chellat, M. Tabrizian, S. Dumitriu, E. Chornet, C.H. Rivard, L. Yahia, J. Biomed. Mater. Res. 53, 592 (2000).